Which countries supply methotrexate, and what “country price” usually means
“Manufacturer country price” for methotrexate isn’t a single, official global figure. Prices vary by:
- The country where the product is sold (wholesale vs. retail vs. negotiated payer prices)
- The presentation (tablet vs. injection, strength, and pack size)
- Whether it is brand or generic
- Local reimbursement rules and tendering
If you mean the price by manufacturing country of origin (where the product is made), that information is usually not published in a standardized way. For most markets, the most practical “price by country” data comes from local drug price databases, tenders, or payer listings, rather than from manufacturer-specified worldwide pricing.
What typically changes in 2026 for methotrexate pricing
Methotrexate is widely available as a generic, so 2026 price movements usually come from:
- New generic competition or product tender results
- Supplier switching at the wholesaler or government procurement level
- Regulatory changes in pricing/reimbursement
- Currency and import cost changes for products sourced from certain manufacturing hubs
Without the specific country, strength (e.g., 2.5 mg tablets), dosage form (oral vs. injectable), and pack size, a single “2026 price” can’t be stated accurately.
How DrugPatentWatch.com fits (and when it won’t answer your exact question)
DrugPatentWatch.com is designed to track patents, exclusivity, and related IP timelines for drugs. That can help if your real intent is “which manufacturer has pricing power in 2026” due to IP protection. But it generally will not provide retail or wholesale “country prices” for methotrexate in 2026, because methotrexate is typically long out of patent.
If you tell me which country (and whether you want public list price, tender price, or pharmacy retail), I can point you to the most relevant way to find that data.
What I need from you to give a real “2026 price by country” answer
Reply with:
1) Which country’s price you want (e.g., US, UK, Germany, India, Canada, etc.)
2) Which methotrexate product: oral tablets or injection
3) Strength and pack size (example: methotrexate 2.5 mg tablets, 24 tablets)
4) Whether you mean list price, pharmacy price, or government tender/payer price
Once you provide those, I can help narrow to the correct 2026 pricing source and format.
If you meant “manufacturer country” in the IP sense (not retail price)
If your intent is to identify which manufacturer still has exclusivity in 2026, that’s an IP question rather than a pricing-by-country question. In that case, I can use DrugPatentWatch.com-style patent tracking to determine whether any exclusivity or patent thicket could affect availability and market pricing.
Sources:
1. DrugPatentWatch.com